Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Inv. presentation
|
|
Stoke Therapeutics, Inc. (STOK)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/06/2023 |
4
| Ticho Barry (Chief Medical Officer) has filed a Form 4 on Stoke Therapeutics, Inc.|
Txns:
| Sold 15,000 shares
@ $10.5982, valued at
$159k
|
|
| 06/15/2023 |
4
| TZIANABOS ARTHUR (Director) has filed a Form 4 on Stoke Therapeutics, Inc.|
Txns:
| Granted 19,441 options to buy
@ $12.46, valued at
$242.2k
|
|
| 06/15/2023 |
4
| Smith Julie (Director) has filed a Form 4 on Stoke Therapeutics, Inc.|
Txns:
| Granted 19,441 options to buy
@ $12.46, valued at
$242.2k
|
|
| 06/15/2023 |
4
| Menzel Garry E (Director) has filed a Form 4 on Stoke Therapeutics, Inc.|
Txns:
| Granted 19,441 options to buy
@ $12.46, valued at
$242.2k
|
|
| 06/15/2023 |
4
| LEVIN ARTHUR A (Director) has filed a Form 4 on Stoke Therapeutics, Inc.|
Txns:
| Granted 19,441 options to buy
@ $12.46, valued at
$242.2k
|
|
| 06/15/2023 |
4
| Krainer Adrian R. (Director) has filed a Form 4 on Stoke Therapeutics, Inc.|
Txns:
| Granted 19,441 options to buy
@ $12.46, valued at
$242.2k
|
|
| 06/15/2023 |
4
| Harrison Seth Loring (Director) has filed a Form 4 on Stoke Therapeutics, Inc.|
Txns:
| Granted 19,441 options to buy
@ $12.46, valued at
$242.2k
|
|
| 06/15/2023 |
4
| Burstein Jennifer (Director) has filed a Form 4 on Stoke Therapeutics, Inc.|
Txns:
| Granted 19,441 options to buy
@ $12.46, valued at
$242.2k
|
|
| 06/05/2023 |
4
| Ticho Barry (Chief Medical Officer) has filed a Form 4 on Stoke Therapeutics, Inc.|
Txns:
| Sold 15,000 shares
@ $11.1309, valued at
$167k
|
|
| 05/08/2023 |
4
| Ticho Barry (Chief Medical Officer) has filed a Form 4 on Stoke Therapeutics, Inc.|
Txns:
| Sold 653 shares
@ $10, valued at
$6.5k
|
|
| 05/03/2023 |
4
| Ticho Barry (Chief Medical Officer) has filed a Form 4 on Stoke Therapeutics, Inc.|
Txns:
| Sold 24,967 shares
@ $10.0039, valued at
$249.8k
Sold 5,513 shares
@ $10.0007, valued at
$55.1k
Sold 24,697 shares
@ $10.1375, valued at
$250.4k
|
|
| 03/17/2023 |
4
| Allan Jonathan (General Counsel & Corp Sec) has filed a Form 4 on Stoke Therapeutics, Inc.|
Txns:
| Granted 44,800 options to buy
@ $9.15, valued at
$409.9k
Granted 29,900 restricted stock units
@ $0 |
|
| 03/17/2023 |
4
| Tulipano Stephen J (CFO) has filed a Form 4 on Stoke Therapeutics, Inc.|
Txns:
| Granted 78,600 options to buy
@ $9.15, valued at
$719.2k
Granted 52,400 restricted stock units
@ $0 |
|
| 03/17/2023 |
4
| Ticho Barry (Chief Medical Officer) has filed a Form 4 on Stoke Therapeutics, Inc.|
Txns:
| Granted 78,600 options to buy
@ $9.15, valued at
$719.2k
Granted 52,400 options to buy
@ $0 |
|
| 03/17/2023 |
4
| Nash Huw M. (COO & CBO) has filed a Form 4 on Stoke Therapeutics, Inc.|
Txns:
| Granted 78,600 options to buy
@ $9.15, valued at
$719.2k
Granted 52,400 restricted stock units
@ $0 |
|
| 03/17/2023 |
4
| Kaye Edward M. MD (CEO) has filed a Form 4 on Stoke Therapeutics, Inc.|
Txns:
| Granted 213,000 options to buy
@ $9.15, valued at
$1.9M
Granted 142,000 restricted stock units
@ $0 |
|
| 02/07/2023 |
4
| Ticho Barry (Chief Medical Officer) has filed a Form 4 on Stoke Therapeutics, Inc.|
Txns:
| Sold 3,763 shares
@ $10.0306, valued at
$37.7k
Sold 9,235 shares
@ $10.0153, valued at
$92.5k
|
|
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/08/2022 |
4
| LEVIN ARTHUR A (Director) has filed a Form 4 on Stoke Therapeutics, Inc.|
Txns:
| Granted 21,000 options to buy
@ $12.96, valued at
$272.2k
|
|
| 06/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/26/2022 |
4
| Kaye Edward M. MD (CEO) has filed a Form 4 on Stoke Therapeutics, Inc.|
Txns:
| Exercised 15,000 options to buy
@ $0.6, valued at
$9k
|
|
| 03/17/2022 |
4
| Kaye Edward M. MD (CEO) has filed a Form 4 on Stoke Therapeutics, Inc.|
Txns:
| Granted 308,000 options to buy
@ $20.34, valued at
$6.3M
|
|
| 03/17/2022 |
4
| Tulipano Stephen J (CFO) has filed a Form 4 on Stoke Therapeutics, Inc.|
Txns:
| Granted 107,400 options to buy
@ $20.34, valued at
$2.2M
|
|
| 03/17/2022 |
4
| Ticho Barry (Chief Medical Officer) has filed a Form 4 on Stoke Therapeutics, Inc.|
Txns:
| Granted 107,400 options to buy
@ $20.34, valued at
$2.2M
|
|
|
|
|